Sign in
Taking people in United StatesNo phase

Studies how the body handles standard drugs given to children with leukemia

Observes how children with acute lymphoblastic leukemia process their usual prescribed medicines.

Key facts

Who runs it
Duke University
Where
Durham, United StatesSee the site
Trial code
Registry title
Pharmacokinetics of Drugs Administered to Children
Status
Recruiting
People taking part
200 people, planned
Started
14 Aug 2013
Expected to end
14 Aug 2033
Type of study
Observational
Treatments tested
  • Standard of care drug
Record updated
7 January 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children and young people under 21 who are already receiving certain drugs as part of their normal care. It studies how the body handles those drugs.

Age
Under 21 years (0 to 20 years)
Sex
All sexes can join.
Earlier treatment
They must be receiving drugs of interest as part of standard care, as prescribed by their treating caregiver.

Main reasons for not taking part

  • Consent or assent not obtained (as indicated)

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Children (< 21 years of age) who are receiving understudied drugs of interest per standard of care as prescribed by their treating caregiver

Who cannot take part

  • Failure to obtain consent/assent (as indicated)

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 0 and 20 years old?

Where in United States

  • Duke UniversityDurham, United StatesContact: Rachel Greenberg, MDTaking people

About the trial

What the trial wants to find out

This is a prospective study of children <21 years of age with the goal of characterizing the PK of drugs administered per standard of care as prescribed by the treating caregiver.

Treatments tested

  • Standard of care drug

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Pharmacokinetics of Drugs Administered to Children Per Standard of Care
Plain-language title
Studies how the body handles standard drugs given to children with leukemiaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT03481881, who can take part
Record updated
7 January 2026